跳至主要内容
临床试验/NCT06821217
NCT06821217招募中不适用

A Mobile Application as Supportive Treatment of Endometriosis: the Effect on Quality of Life and Endometriosis-associated Pain. A Randomized Controlled Trial.

Insel Gruppe AG, University Hospital Bern1 个研究点 分布在 1 个国家目标入组 308 人开始时间: 2024年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
308
试验地点
1
主要终点
Life quality

研究概览

简要总结

The goal of this clinical trial is to learn if an App-based intervention affects the quality of life in patients with suspected or confirmed endometriosis. The main questions it aims to answer are:

  • Does the App-based intervention improve the quality of life?
  • Does it lead to pain relief? Researchers will compare participants using the App to a control group to see if the App works to improve quality of life and endometriosis-related symptoms.

Participants will:

  • Use an App-based intervention or be in the control group (no App-use) for 6 months
  • Visit or have a telephone consultation after 3 and 6 months
  • Complete a questionnaire to assess the quality of life at inclusion, after 1, 3 and 6 months

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Informed Consent as documented by signature
  • •Age 18 or older
  • •Premenopausal status (menopause is defined as amenorrhea lasting one year or longer)
  • •Endometriosis, confirmed by surgery or clinically suspected
  • •Possession of a smartphone

排除标准

  • •Planned endometriosis surgery or planned hormonal therapy in the study period
  • •Surgery and/or new hormonal therapy in the last three months
  • •Malignant diseases
  • •Pregnancy
  • •Breastfeeding
  • •Active desire for pregnancy in the study period
  • •Fertility treatment
  • •Simultaneous participation in other intervention studies

研究组 & 干预措施

Control group with clinically suspected endometriosis

No Intervention

Intervention group with histologically confirmed endometriosis

Experimental

干预措施: NALU Endo Flow App (Device)

Control group with histologically confirmed endometriosis

No Intervention

Intervention group with clinically suspected endometriosis

Experimental

干预措施: NALU Endo Flow App (Device)

结局指标

主要结局

Life quality

时间窗: 6 months

The primary endpoint will be the change in quality of life in App users assessed by the EHP-30 questionnaire (Endometriosis-Health-Profile-Questionnaire: The questions can be divided into five subscales covering 'pain', 'control and powerlessness', 'social support', 'emotional wellbeing' and 'self-image'. The questionnaire is standardized on a scale from 0 to 100, with lower scores indicating better quality of life.

次要结局

  • Pain relief(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验